Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users.

Published

Journal Article

The diagnosis and confirmation of human T cell lymphotropic virus (HTLV) type II infection has proven difficult, since most assays depend on antigenic cross-reactivity between HTLV-I antigens and HTLV-II antibodies. Type-specific HTLV infection rates were evaluated in a cohort of 233 injecting drug users screened with an HTLV EIA. Of the 52 EIA-reactive specimens, 48 were indeterminate or negative by standard Western blot. Type-specific HTLV results determined by polymerase chain reaction (PCR) were 0, HTLV-I; 92%, HTLV-II; 6%, type indeterminate; and 2%, negative. Among 42 EIA-reactive, HTLV-II-PCR-positive individuals tested by a p21 envr Western blot, all were positive and 74% had antibodies to the tax protein. This study found a high rate (22.3%) of HTLV reactivity, with HTLV-II usually the sole responsible agent; shortcomings in standard HTLV-I-based diagnostics but usefulness of PCR and p21 envr Western blots for typing and confirmation of HTLV reactivity; and a high prevalence (74%) of anti-tax antibody among HTLV-II-seropositive subjects, suggesting increased potential for infectivity.

Full Text

Duke Authors

Cited Authors

  • Palumbo, PE; Weiss, SH; McCreedy, BJ; Alexander, SS; Denny, TN; Klein, CW; Altman, R

Published Date

  • October 1992

Published In

Volume / Issue

  • 166 / 4

Start / End Page

  • 896 - 899

PubMed ID

  • 1527427

Pubmed Central ID

  • 1527427

International Standard Serial Number (ISSN)

  • 0022-1899

Digital Object Identifier (DOI)

  • 10.1093/infdis/166.4.896

Language

  • eng

Conference Location

  • United States